Sandra Levy
ARTICLES BY THIS AUTHOR
- 3/22/2021
Biogen sues Teva over generic Vumerity
Biogen and Alkermes claim that Teva’s generic infringes three patents that protect Vumerity, which Alkermes licenses exclusively to Biogen. - 3/22/2021
Study finds Medicare Part D plans adding more generic drugs onto non-preferred drug tier
A study from Avalere, funded by the Association for Accessible Medicines, found that in 2021, Medicare Part D plans placed generic prescription drugs on generic tiers 45% of the time, a decrease from 64% in 2016. - 3/22/2021
Glenmark obtains FDA OK for generic Cardizem
Cardizem had a market value of approximately $56.7 million for the 12 months ended January 2021, according to IQVIA. - 3/21/2021
Hy-Vee to host 2nd ‘Best of Local Brands’ summit in May
Hy-Vee once again is inviting Midwestern vendors to submit their products for potential distribution on its shelves. - 3/21/2021
Journey Medical in-licenses, launches Accutane
Journey Medical is adding Accutane to its portfolio of dermatology products. - 3/21/2021
Oakrum, Aucta gain FDA nod for generic Jadenu
Deferasirox granules had a market value exceeding $31 million for the 12-month period ending January 2021, according to IQVIA. - 3/21/2021
Trial data: AstraZeneca's COVID-19 vaccine protects 100% against severe disease, hospitalization
AstraZeneca will continue to analyze the new data and prepare to apply in the coming weeks for emergency use from the FDA. - 3/21/2021
Aveo intros oral renal cell carcinoma treatment Fotivda
The medication is an oral, next generation vascular endothelial growth factor tyrosine kinase inhibitor. - 3/18/2021
Janssen obtains FDA approval for Ponvory
Janssen’s Ponvory is an oral treatment for adults with relapsing forms of multiple sclerosis. - 3/18/2021
APhA Foundation adds board member, elects officers
The American Pharmacists Association Foundation named Elizabeth Johnson and established a new slate of officers for the 2021 one-year term.
